Sysmex Corporation, Japan, completes outright acquisition of Astrego Diagnostics AB.

On 23rd March 2022, we proudly announced that Astrego’s first product is CE-IVD marked!

Astrego´s Quality Management System is certified to ISO 13485:2016


Astrego’s disruptive technology makes it possible to capture individual bacterial cells from complex samples and measure their growth rate in real-time. This enables the fastest possible Antibiotic Susceptibility Test (AST).


Products targeting a wide range of microbiological applications, designed to enable evidence-based prescription of antibiotics and help reduce the spread of antimicrobial resistance (AMR).


Astrego Diagnostics is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. Our team combines multidisciplinary scientific excellence with seasoned diagnostic industry management.

This website use cookies.
By using the website you consent to this.
Read more here.